table of content
1 Introduction to Research & Analysis Reports
1.1 Anti-obesity Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-obesity Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-obesity Drugs Overall Market Size
2.1 Global Anti-obesity Drugs Market Size: 2021 VS 2028
2.2 Global Anti-obesity Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-obesity Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Anti-obesity Drugs Players in Global Market
3.2 Top Global Anti-obesity Drugs Companies Ranked by Revenue
3.3 Global Anti-obesity Drugs Revenue by Companies
3.4 Global Anti-obesity Drugs Sales by Companies
3.5 Global Anti-obesity Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-obesity Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-obesity Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-obesity Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-obesity Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-obesity Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-obesity Drugs Market Size Markets, 2021 & 2028
4.1.2 Peripherally Acting Anti-obesity Drugs
4.1.3 Centrally Acting Anti-obesity Drugs
4.2 By Type - Global Anti-obesity Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-obesity Drugs Revenue, 2017-2022
4.2.2 By Type - Global Anti-obesity Drugs Revenue, 2023-2028
4.2.3 By Type - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-obesity Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-obesity Drugs Sales, 2017-2022
4.3.2 By Type - Global Anti-obesity Drugs Sales, 2023-2028
4.3.3 By Type - Global Anti-obesity Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Anti-obesity Drugs Market Size, 2021 & 2028
5.1.2 Kids
5.1.3 Adults
5.2 By Application - Global Anti-obesity Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-obesity Drugs Revenue, 2017-2022
5.2.2 By Application - Global Anti-obesity Drugs Revenue, 2023-2028
5.2.3 By Application - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-obesity Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-obesity Drugs Sales, 2017-2022
5.3.2 By Application - Global Anti-obesity Drugs Sales, 2023-2028
5.3.3 By Application - Global Anti-obesity Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Anti-obesity Drugs Market Size, 2021 & 2028
6.2 By Region - Global Anti-obesity Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-obesity Drugs Revenue, 2017-2022
6.2.2 By Region - Global Anti-obesity Drugs Revenue, 2023-2028
6.2.3 By Region - Global Anti-obesity Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-obesity Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-obesity Drugs Sales, 2017-2022
6.3.2 By Region - Global Anti-obesity Drugs Sales, 2023-2028
6.3.3 By Region - Global Anti-obesity Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Anti-obesity Drugs Revenue, 2017-2028
6.4.2 By Country - North America Anti-obesity Drugs Sales, 2017-2028
6.4.3 US Anti-obesity Drugs Market Size, 2017-2028
6.4.4 Canada Anti-obesity Drugs Market Size, 2017-2028
6.4.5 Mexico Anti-obesity Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Anti-obesity Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Anti-obesity Drugs Sales, 2017-2028
6.5.3 Germany Anti-obesity Drugs Market Size, 2017-2028
6.5.4 France Anti-obesity Drugs Market Size, 2017-2028
6.5.5 U.K. Anti-obesity Drugs Market Size, 2017-2028
6.5.6 Italy Anti-obesity Drugs Market Size, 2017-2028
6.5.7 Russia Anti-obesity Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Anti-obesity Drugs Market Size, 2017-2028
6.5.9 Benelux Anti-obesity Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Anti-obesity Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Anti-obesity Drugs Sales, 2017-2028
6.6.3 China Anti-obesity Drugs Market Size, 2017-2028
6.6.4 Japan Anti-obesity Drugs Market Size, 2017-2028
6.6.5 South Korea Anti-obesity Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Anti-obesity Drugs Market Size, 2017-2028
6.6.7 India Anti-obesity Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Anti-obesity Drugs Revenue, 2017-2028
6.7.2 By Country - South America Anti-obesity Drugs Sales, 2017-2028
6.7.3 Brazil Anti-obesity Drugs Market Size, 2017-2028
6.7.4 Argentina Anti-obesity Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-obesity Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Anti-obesity Drugs Sales, 2017-2028
6.8.3 Turkey Anti-obesity Drugs Market Size, 2017-2028
6.8.4 Israel Anti-obesity Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Anti-obesity Drugs Market Size, 2017-2028
6.8.6 UAE Anti-obesity Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Anti-obesity Drugs Major Product Offerings
7.1.4 Merck Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Merck Key News
7.2 Novo Nordisk
7.2.1 Novo Nordisk Corporate Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Anti-obesity Drugs Major Product Offerings
7.2.4 Novo Nordisk Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Novo Nordisk Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Anti-obesity Drugs Major Product Offerings
7.3.4 Pfizer Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Corporate Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Anti-obesity Drugs Major Product Offerings
7.4.4 Arena Pharmaceuticals Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Arena Pharmaceuticals Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Anti-obesity Drugs Major Product Offerings
7.5.4 Roche Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Roche Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Anti-obesity Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Corporate Summary
7.7.2 Orexigen Therapeutics Business Overview
7.7.3 Orexigen Therapeutics Anti-obesity Drugs Major Product Offerings
7.7.4 Orexigen Therapeutics Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Orexigen Therapeutics Key News
7.8 Vivus
7.8.1 Vivus Corporate Summary
7.8.2 Vivus Business Overview
7.8.3 Vivus Anti-obesity Drugs Major Product Offerings
7.8.4 Vivus Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Vivus Key News
7.9 Amylin
7.9.1 Amylin Corporate Summary
7.9.2 Amylin Business Overview
7.9.3 Amylin Anti-obesity Drugs Major Product Offerings
7.9.4 Amylin Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Amylin Key News
7.10 Alizyme
7.10.1 Alizyme Corporate Summary
7.10.2 Alizyme Business Overview
7.10.3 Alizyme Anti-obesity Drugs Major Product Offerings
7.10.4 Alizyme Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Alizyme Key News
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Corporate Summary
7.11.2 Boehringer Ingelheim Anti-obesity Drugs Business Overview
7.11.3 Boehringer Ingelheim Anti-obesity Drugs Major Product Offerings
7.11.4 Boehringer Ingelheim Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Boehringer Ingelheim Key News
7.12 Eisai
7.12.1 Eisai Corporate Summary
7.12.2 Eisai Anti-obesity Drugs Business Overview
7.12.3 Eisai Anti-obesity Drugs Major Product Offerings
7.12.4 Eisai Anti-obesity Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Eisai Key News
8 Global Anti-obesity Drugs Production Capacity, Analysis
8.1 Global Anti-obesity Drugs Production Capacity, 2017-2028
8.2 Anti-obesity Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-obesity Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-obesity Drugs Supply Chain Analysis
10.1 Anti-obesity Drugs Industry Value Chain
10.2 Anti-obesity Drugs Upstream Market
10.3 Anti-obesity Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-obesity Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
